nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—Acneiform eruption—Disulfiram—alcohol dependence	0.116	0.194	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Disulfiram—alcohol dependence	0.0859	0.143	CcSEcCtD
Fluocinonide—Eruption—Disulfiram—alcohol dependence	0.0477	0.0796	CcSEcCtD
Fluocinonide—Miliaria—Naltrexone—alcohol dependence	0.0465	0.0777	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Citalopram—alcohol dependence	0.0254	0.0423	CcSEcCtD
Fluocinonide—Hypertrichosis—Citalopram—alcohol dependence	0.0228	0.038	CcSEcCtD
Fluocinonide—SMO—adrenal cortex—alcohol dependence	0.0226	0.0877	CbGeAlD
Fluocinonide—SMO—midbrain—alcohol dependence	0.0161	0.0625	CbGeAlD
Fluocinonide—NR3C1—nerve—alcohol dependence	0.0142	0.0551	CbGeAlD
Fluocinonide—SMO—endocrine gland—alcohol dependence	0.0141	0.0549	CbGeAlD
Fluocinonide—Folliculitis—Citalopram—alcohol dependence	0.0138	0.023	CcSEcCtD
Fluocinonide—SMO—testis—alcohol dependence	0.0135	0.0524	CbGeAlD
Fluocinonide—SMO—nervous system—alcohol dependence	0.0132	0.0514	CbGeAlD
Fluocinonide—SMO—liver—alcohol dependence	0.0127	0.0495	CbGeAlD
Fluocinonide—SMO—central nervous system—alcohol dependence	0.0127	0.0495	CbGeAlD
Fluocinonide—SMO—cerebellum—alcohol dependence	0.0124	0.0484	CbGeAlD
Fluocinonide—Swelling—Naltrexone—alcohol dependence	0.0113	0.0188	CcSEcCtD
Fluocinonide—Nasal congestion—Naltrexone—alcohol dependence	0.0109	0.0182	CcSEcCtD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—CRHR1—alcohol dependence	0.0104	0.0724	CbGpPWpGaD
Fluocinonide—SMO—brain—alcohol dependence	0.0101	0.0393	CbGeAlD
Fluocinonide—Dry skin—Acamprosate—alcohol dependence	0.00962	0.0161	CcSEcCtD
Fluocinonide—SMO—GPCRs, Other—CHRM2—alcohol dependence	0.00944	0.0656	CbGpPWpGaD
Fluocinonide—SERPINA6—blood—alcohol dependence	0.00896	0.0349	CbGeAlD
Fluocinonide—Pain—Disulfiram—alcohol dependence	0.00895	0.0149	CcSEcCtD
Fluocinonide—Nasopharyngitis—Naltrexone—alcohol dependence	0.00888	0.0148	CcSEcCtD
Fluocinonide—Dermatitis contact—Citalopram—alcohol dependence	0.00856	0.0143	CcSEcCtD
Fluocinonide—Hyperglycaemia—Acamprosate—alcohol dependence	0.00818	0.0137	CcSEcCtD
Fluocinonide—SMO—Class B/2 (Secretin family receptors)—CRH—alcohol dependence	0.00798	0.0555	CbGpPWpGaD
Fluocinonide—SERPINA6—endocrine gland—alcohol dependence	0.00778	0.0302	CbGeAlD
Fluocinonide—SERPINA6—nervous system—alcohol dependence	0.00728	0.0283	CbGeAlD
Fluocinonide—SERPINA6—liver—alcohol dependence	0.00701	0.0273	CbGeAlD
Fluocinonide—SERPINA6—central nervous system—alcohol dependence	0.00701	0.0273	CbGeAlD
Fluocinonide—Dizziness—Disulfiram—alcohol dependence	0.00692	0.0116	CcSEcCtD
Fluocinonide—Nasal congestion—Citalopram—alcohol dependence	0.0069	0.0115	CcSEcCtD
Fluocinonide—SERPINA6—cerebellum—alcohol dependence	0.00685	0.0266	CbGeAlD
Fluocinonide—SMO—GPCRs, Other—DRD4—alcohol dependence	0.00673	0.0468	CbGpPWpGaD
Fluocinonide—Rash—Disulfiram—alcohol dependence	0.0066	0.011	CcSEcCtD
Fluocinonide—Headache—Disulfiram—alcohol dependence	0.00656	0.0109	CcSEcCtD
Fluocinonide—Immune system disorder—Acamprosate—alcohol dependence	0.00656	0.0109	CcSEcCtD
Fluocinonide—SMO—GPCRs, Other—CNR1—alcohol dependence	0.00642	0.0447	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—HTR7—alcohol dependence	0.00627	0.0436	CbGpPWpGaD
Fluocinonide—Immune system disorder—Naltrexone—alcohol dependence	0.0062	0.0104	CcSEcCtD
Fluocinonide—NR3C1—brainstem—alcohol dependence	0.00608	0.0237	CbGeAlD
Fluocinonide—NR3C1—forebrain—alcohol dependence	0.00587	0.0228	CbGeAlD
Fluocinonide—Dry skin—Citalopram—alcohol dependence	0.00576	0.00962	CcSEcCtD
Fluocinonide—Nasopharyngitis—Citalopram—alcohol dependence	0.00562	0.00939	CcSEcCtD
Fluocinonide—SERPINA6—brain—alcohol dependence	0.00556	0.0216	CbGeAlD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—HTR7—alcohol dependence	0.00554	0.0385	CbGpPWpGaD
Fluocinonide—NR3C1—adrenal cortex—alcohol dependence	0.00544	0.0212	CbGeAlD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Acamprosate—alcohol dependence	0.00534	0.00892	CcSEcCtD
Fluocinonide—Infection—Acamprosate—alcohol dependence	0.00512	0.00855	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Naltrexone—alcohol dependence	0.00505	0.00844	CcSEcCtD
Fluocinonide—Skin disorder—Acamprosate—alcohol dependence	0.00501	0.00836	CcSEcCtD
Fluocinonide—NR3C1—cardiovascular system—alcohol dependence	0.00496	0.0193	CbGeAlD
Fluocinonide—Hyperglycaemia—Citalopram—alcohol dependence	0.0049	0.00818	CcSEcCtD
Fluocinonide—Infection—Naltrexone—alcohol dependence	0.00485	0.00809	CcSEcCtD
Fluocinonide—NR3C1—pancreas—alcohol dependence	0.00483	0.0188	CbGeAlD
Fluocinonide—Nervous system disorder—Naltrexone—alcohol dependence	0.00478	0.00799	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—OPRK1—alcohol dependence	0.00475	0.033	CbGpPWpGaD
Fluocinonide—Skin disorder—Naltrexone—alcohol dependence	0.00474	0.00791	CcSEcCtD
Fluocinonide—NR3C1—gonad—alcohol dependence	0.00451	0.0175	CbGeAlD
Fluocinonide—Pain—Acamprosate—alcohol dependence	0.00441	0.00736	CcSEcCtD
Fluocinonide—SMO—GPCRs, Other—HTR2A—alcohol dependence	0.00439	0.0305	CbGpPWpGaD
Fluocinonide—Pain—Naltrexone—alcohol dependence	0.00417	0.00696	CcSEcCtD
Fluocinonide—NR3C1—digestive system—alcohol dependence	0.00412	0.016	CbGeAlD
Fluocinonide—Immune system disorder—Citalopram—alcohol dependence	0.00393	0.00656	CcSEcCtD
Fluocinonide—NR3C1—blood—alcohol dependence	0.00393	0.0153	CbGeAlD
Fluocinonide—NR3C1—midbrain—alcohol dependence	0.00388	0.0151	CbGeAlD
Fluocinonide—Hypersensitivity—Acamprosate—alcohol dependence	0.0038	0.00634	CcSEcCtD
Fluocinonide—Erythema—Citalopram—alcohol dependence	0.00379	0.00632	CcSEcCtD
Fluocinonide—Pruritus—Acamprosate—alcohol dependence	0.00365	0.00609	CcSEcCtD
Fluocinonide—Hypersensitivity—Naltrexone—alcohol dependence	0.00359	0.006	CcSEcCtD
Fluocinonide—Pruritus—Naltrexone—alcohol dependence	0.00345	0.00576	CcSEcCtD
Fluocinonide—Dizziness—Acamprosate—alcohol dependence	0.00341	0.00569	CcSEcCtD
Fluocinonide—NR3C1—endocrine gland—alcohol dependence	0.00341	0.0132	CbGeAlD
Fluocinonide—Rash—Acamprosate—alcohol dependence	0.00325	0.00543	CcSEcCtD
Fluocinonide—Dermatitis—Acamprosate—alcohol dependence	0.00325	0.00542	CcSEcCtD
Fluocinonide—NR3C1—testis—alcohol dependence	0.00325	0.0126	CbGeAlD
Fluocinonide—Headache—Acamprosate—alcohol dependence	0.00323	0.00539	CcSEcCtD
Fluocinonide—Dizziness—Naltrexone—alcohol dependence	0.00323	0.00538	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Citalopram—alcohol dependence	0.0032	0.00535	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—OPRD1—alcohol dependence	0.00319	0.0222	CbGpPWpGaD
Fluocinonide—NR3C1—nervous system—alcohol dependence	0.00319	0.0124	CbGeAlD
Fluocinonide—Rash—Naltrexone—alcohol dependence	0.00308	0.00513	CcSEcCtD
Fluocinonide—Dermatitis—Naltrexone—alcohol dependence	0.00307	0.00513	CcSEcCtD
Fluocinonide—Infection—Citalopram—alcohol dependence	0.00307	0.00513	CcSEcCtD
Fluocinonide—NR3C1—liver—alcohol dependence	0.00307	0.0119	CbGeAlD
Fluocinonide—NR3C1—central nervous system—alcohol dependence	0.00307	0.0119	CbGeAlD
Fluocinonide—SMO—GPCR ligand binding—PDYN—alcohol dependence	0.00306	0.0213	CbGpPWpGaD
Fluocinonide—Headache—Naltrexone—alcohol dependence	0.00306	0.0051	CcSEcCtD
Fluocinonide—Nervous system disorder—Citalopram—alcohol dependence	0.00303	0.00506	CcSEcCtD
Fluocinonide—Skin disorder—Citalopram—alcohol dependence	0.003	0.00501	CcSEcCtD
Fluocinonide—NR3C1—cerebellum—alcohol dependence	0.003	0.0117	CbGeAlD
Fluocinonide—SMO—GPCR ligand binding—CRHR1—alcohol dependence	0.00285	0.0198	CbGpPWpGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—AVP—alcohol dependence	0.00274	0.019	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CHRM2—alcohol dependence	0.00268	0.0186	CbGpPWpGaD
Fluocinonide—Pain—Citalopram—alcohol dependence	0.00264	0.00441	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—OPRM1—alcohol dependence	0.00246	0.0171	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—OPRK1—alcohol dependence	0.00244	0.017	CbGpPWpGaD
Fluocinonide—NR3C1—brain—alcohol dependence	0.00244	0.00948	CbGeAlD
Fluocinonide—Hypersensitivity—Citalopram—alcohol dependence	0.00228	0.0038	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—NPY—alcohol dependence	0.00226	0.0157	CbGpPWpGaD
Fluocinonide—Pruritus—Citalopram—alcohol dependence	0.00219	0.00365	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—HTR1B—alcohol dependence	0.00218	0.0152	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CRH—alcohol dependence	0.00218	0.0152	CbGpPWpGaD
Fluocinonide—Dizziness—Citalopram—alcohol dependence	0.00204	0.00341	CcSEcCtD
Fluocinonide—NR3C1—Circadian Clock—AVP—alcohol dependence	0.00199	0.0139	CbGpPWpGaD
Fluocinonide—Rash—Citalopram—alcohol dependence	0.00195	0.00325	CcSEcCtD
Fluocinonide—Dermatitis—Citalopram—alcohol dependence	0.00195	0.00325	CcSEcCtD
Fluocinonide—Headache—Citalopram—alcohol dependence	0.00194	0.00323	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—DRD4—alcohol dependence	0.00191	0.0133	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CNR1—alcohol dependence	0.00182	0.0127	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR7—alcohol dependence	0.00178	0.0124	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—DRD2—alcohol dependence	0.00178	0.0124	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—OPRD1—alcohol dependence	0.00164	0.0114	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—PDYN—alcohol dependence	0.00157	0.0109	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—CHRM2—alcohol dependence	0.00155	0.0108	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—AVP—alcohol dependence	0.0015	0.0104	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CRHR1—alcohol dependence	0.00146	0.0102	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—OPRK1—alcohol dependence	0.00144	0.01	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CHRM2—alcohol dependence	0.00137	0.00955	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—EP300—alcohol dependence	0.00129	0.00893	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—OPRM1—alcohol dependence	0.00126	0.00877	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—HTR2A—alcohol dependence	0.00124	0.00865	CbGpPWpGaD
Fluocinonide—NR3C1—BMAL1:CLOCK,NPAS2 activates circadian gene expression—EP300—alcohol dependence	0.00121	0.00839	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—SLC6A4—alcohol dependence	0.00117	0.00817	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—NPY—alcohol dependence	0.00116	0.00807	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR1B—alcohol dependence	0.00112	0.00778	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CRH—alcohol dependence	0.00112	0.00778	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—POMC—alcohol dependence	0.000994	0.00691	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—DRD4—alcohol dependence	0.000979	0.0068	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—OPRD1—alcohol dependence	0.000968	0.00673	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—alcohol dependence	0.000963	0.00669	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CNR1—alcohol dependence	0.000934	0.0065	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PDYN—alcohol dependence	0.000928	0.00645	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—DRD2—alcohol dependence	0.000912	0.00634	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR7—alcohol dependence	0.000912	0.00634	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of Androgen receptor activity—EP300—alcohol dependence	0.000905	0.00629	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—MAOA—alcohol dependence	0.000884	0.00615	CbGpPWpGaD
Fluocinonide—NR3C1—Circadian Clock—EP300—alcohol dependence	0.000879	0.00611	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—AVP—alcohol dependence	0.000866	0.00602	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CRHR1—alcohol dependence	0.000863	0.006	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—WASF2—alcohol dependence	0.000863	0.006	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—WASF1—alcohol dependence	0.000827	0.00575	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CHRM2—alcohol dependence	0.000811	0.00564	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—AVP—alcohol dependence	0.000767	0.00533	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—OPRM1—alcohol dependence	0.000745	0.00518	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—EP300—alcohol dependence	0.000725	0.00504	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—HTR2A—alcohol dependence	0.000721	0.00501	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—CCAR1—alcohol dependence	0.000687	0.00477	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—NPY—alcohol dependence	0.000685	0.00477	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR1B—alcohol dependence	0.000661	0.0046	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CRH—alcohol dependence	0.000661	0.0046	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—EP300—alcohol dependence	0.000645	0.00448	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—EP300—alcohol dependence	0.000639	0.00444	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—HTR2A—alcohol dependence	0.000638	0.00444	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DRD4—alcohol dependence	0.000578	0.00402	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CNR1—alcohol dependence	0.000552	0.00384	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—DRD2—alcohol dependence	0.000539	0.00374	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR7—alcohol dependence	0.000539	0.00374	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—POMC—alcohol dependence	0.00051	0.00355	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—AVP—alcohol dependence	0.000453	0.00315	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—EP300—alcohol dependence	0.000382	0.00265	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—HTR2A—alcohol dependence	0.000377	0.00262	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—POMC—alcohol dependence	0.000301	0.00209	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—EP300—alcohol dependence	0.0002	0.00139	CbGpPWpGaD
